TG THERAPEUTICS INC (TGTX) Stock Cash Flow
NASDAQ:TGTX - Nasdaq - US88322Q1085 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 39.15M | 23.38M | 12.67M | -198.34M | -348.10M | |||
| Depreciation Amortization | 47.00K | 68.00K | 211.00K | 303.00K | 282.00K | |||
| Change In Working Capital | -151.56M | -109.08M | -84.45M | -1.44M | -12.00M | |||
| Interest Paid | 22.16M | 18.47M | 8.77M | 5.45M | 3.47M | |||
| Taxes Paid | N/A | 500.00K | N/A | N/A | N/A | |||
| Other non cash items | 51.34M | 45.12M | 40.15M | 23.30M | 64.19M | |||
| OPERATING CASH FLOW | -61.02M | -40.52M | -31.41M | -176.17M | -295.63M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -45.00K | 0.00 | -14.00K | -401.00K | |||
| Other Investing Activity | -4.64M | -991.00K | -50.65M | -20.00M | 69.00K | |||
| INVESTING CASH FLOW | -4.71M | -1.04M | -50.65M | -20.01M | -332.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 137.26M | 25.00M | -975.00K | 40.00M | |||
| Stock Issued/Repurchased | -13.96M | -7.85M | 47.83M | 584.00K | 2.44M | |||
| Other Financing Activity | N/A | -889.00K | -125.00K | 0.00 | -1.02M | |||
| FINANCING CASH FLOW | 122.41M | 128.53M | 72.70M | -391.00K | 41.42M | |||
| CHANGE IN CASH | 56.67M | 86.97M | -9.36M | -196.57M | -254.55M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -61.02M | -40.52M | -31.41M | -176.17M | -295.63M | |||
| Capital Expenditure | N/A | -45.00K | 0.00 | -14.00K | -401.00K | |||
| FREE CASH FLOW | -61.09M | -40.56M | -31.41M | -176.18M | -296.04M | |||
All data in USD